Skip to main content
. 2017 Sep 8;7:11009. doi: 10.1038/s41598-017-11188-y

Figure 1.

Figure 1

Distinct SPM profiles in IL-1β stimulated healthy and diseased tendon stromal cells. Tendon stromal cells (60,000 cells per well) were derived from healthy hamstring (n = 8 donors) or diseased supraspinatus tendons (n = 8 donors). Cells were cultured in DMEM F12 phenol red free medium containing 1% heat inactivated human serum to 80% confluence and incubated with IL-1β for 24 h. Media and cells were harvested and placed in ice-cold methanol containing deuterium labeled internal standards. LM were then extracted and profiled. (A) 2-dimensional score plot and (B) corresponding 2-dimensional loading plot of plasma LM-SPM from human tendon derived-stromal cell incubations isolated from healthy volunteers or patients with tendinopathy after stimulation with IL-1β (10ngml—1) for 24 h. Grey ellipse in the score plot denotes 95% confidence regions. (C) Concentrations for mediators found to be differentially regulated between healthy (grey bars) and diseased (black bars) tendon stromal cell incubations. Results are shown as means and SEM and representative of n = 8 donors per group. (D) mRNA expression of lipid mediator biosynthetic enzymes determines using real time qPCR. Gene expression is normalized to β-actin, bars show median values. (E) Representative immunofluorescence images showing staining for ALOX15 (green), PTGS2 (red) and nuclei (cyan) in IL-1β-stimulated healthy and diseased tendon cells. Scale bar, 20μm. Results are representative of n = 3 donors.